Humana Inc. Files 8-K for Regulation FD Disclosure

Ticker: HUM · Form: 8-K · Filed: 2025-08-29T00:00:00.000Z

Sentiment: neutral

Topics: regulation-fd, disclosure

Related Tickers: HUM

TL;DR

Humana filed an 8-K today for a Reg FD disclosure. Details TBD.

AI Summary

On August 29, 2025, Humana Inc. filed a Form 8-K to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, but it is a current report filed on the specified date.

Why It Matters

This filing indicates Humana Inc. is making a public disclosure under Regulation FD, which ensures all investors receive important information simultaneously.

Risk Assessment

Risk Level: low — The filing is a standard regulatory disclosure and does not inherently present new risks.

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD by Humana Inc.?

The provided filing excerpt does not specify the content of the Regulation FD disclosure, only that one was made on August 29, 2025.

What is the significance of a Form 8-K filing for Regulation FD?

A Form 8-K filing for Regulation FD ensures that material non-public information is disclosed to the public in a timely and non-discriminatory manner.

When was this Form 8-K filed by Humana Inc.?

The Form 8-K was filed on August 29, 2025.

What is Humana Inc.'s principal executive office address?

Humana Inc.'s principal executive offices are located at 500 West Main Street, Louisville, Kentucky 40202.

What is Humana Inc.'s IRS Employer Identification Number?

Humana Inc.'s IRS Employer Identification Number is 61-0647538.

From the Filing

0000049071-25-000044.txt : 20250829 0000049071-25-000044.hdr.sgml : 20250829 20250829163011 ACCESSION NUMBER: 0000049071-25-000044 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250829 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20250829 DATE AS OF CHANGE: 20250829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 251281328 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 8-K 1 hum-20250829.htm 8-K hum-20250829 0000049071 false 0000049071 2025-08-29 2025-08-29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2025 ( August 29, 2025 ) Humana Inc. (Exact name of registrant as specified in its charter) Delaware 001-5975 61-0647538 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 500 West Main Street , Louisville , Kentucky 40202 (Address of principal executive offices, including zip code) ( 502 ) 580-1000 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock HUM New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 7.01. Regulation FD Disclosure. Members of Humana Inc.’s (the “Company”) senior management team are scheduled to meet with investors and analysts at various meetings between September 1, 2025 and September 30, 2025. During these meetings, the Company intends to reaffirm its guidance of approximately $13.77 in diluted earnings per common share (“EPS”) or approximately $17.00 in adjusted earnings per common share (“Adjusted EPS”), in each case for the year ending December 31, 2025 (“FY 2025”). This guidance is consistent with the guidance issued in the Company’s press release dated July 30, 2025. As indicated on the Company’s second quarter 2025 earnings call on July 30, 2025, the Company will not be commenting on 202

View on Read The Filing